Scientists Battle In Court Over Lucrative Patents For Gene-Editing Tool
A gene-editing technology called CRISPR-cas9 could be a gold mine for its inventors, but it's not clear who owns the idea. U.S. patent judges will soon hear oral arguments to decide the issue.
No comments:
Post a Comment